Assessment of the haemodynamic response to exercise by means of electrical impedance cardiography: method, validation and clinical applications

A Controlled Trial of Inhaled Bronchodilators in Familial Dysautonomia

BACKGROUND

Chronic lung disease is a leading cause of premature death in patients with familial dysautonomia (FD). A significant number of patients have obstructive airway disease, yet it is not known whether this is pharmacologically reversible.

METHODS

We conducted a double-blind, placebo-controlled, randomized clinical trial comparing the beta 2 agonist albuterol with the muscarinic blocker ipratropium bromide in patients homozygous for the IKBKAP founder mutation. Albuterol, ipratropium bromide, and placebo were administered on 3 separate days via nebulizer in the seated position. Airway responsiveness was evaluated using spirometry and impulse oscillometry 30 min post dose. Cardiovascular effects were evaluated by continuous monitoring of blood pressure, RR intervals, cardiac output, and systemic vascular resistance.

RESULTS

A total of 14 patients completed the trial. Neither active agent had significant detrimental effects on heart rate or rhythm or blood pressure. Albuterol and ipratropium were similar in their bronchodilator effectiveness causing significant improvement in forced expiratory volume in 1-s (FEV1, p = 0.002 and p = 0.030). Impulse oscillometry measures were consistent with a reduction in total airway resistance post nebulization (resistance at 5 Hz p < 0.006).

CONCLUSION

Airway obstruction is pharmacologically reversible in a number of patients with FD. In the short term, both albuterol and ipratropium were well tolerated and not associated with major cardiovascular adverse events.

Interval and continuous exercise elicit equivalent postexercise hypotension in prehypertensive men, despite differences in regulation

Equicaloric bouts of interval (IE: 5 × 2:2 min at 85% and 40% maximal oxygen uptake) and steady state (SS: 21 min at 60% maximal oxygen uptake) exercise were performed by 13 older prehypertensive males on separate days, at equivalent times of day, to assess the influence of exercise mode on postexercise hypotension (PEH). Exercise conditions were compared with a control session. Cardiovascular measures were collected for 30 min prior to, and 60 min following exercise. PEH, as measured by mean postexercise systolic blood pressure (SBP) decrease (IE: -4 ± 6 mm Hg; SS: -3 ± 4 mm Hg; control: 4 ± 4 mm Hg), area under the SBP curve (IE: -240 ± 353 mm Hg·min; SS: -192 ± 244 mm Hg·min), and minimum SBP achieved (IE: -15 ± 7 mm Hg; SS: -13 ± 7 mm Hg), was equivalent after both conditions. Stroke volume was significantly reduced (IE: -14.6 ± 16.0 mL; SS: -10.1 ± 14.2 mL, control -1.7 ± 2.2 mL) and heart rate was significantly elevated (IE: 13 ± 8 beats·min⁻¹; SS: 7.9 ± 8 beats·min⁻¹; control: -2 ± 3 beats·min⁻¹) postexercise after both conditions. Cardiac output and total peripheral resistance were nonsignificantly decreased and increased postexercise, respectively. Baroreflex sensitivity (BRS) was reduced following IE (p < 0.05) and heart rate variability (HRV) parameters were reduced after both conditions, with IE eliciting larger and longer reductions in some indices. The results from the current study indicate that older prehypertensive adults experience similar PEH following equicaloric bouts of IE and SS exercise despite larger alterations in HRV and BRS elicited by IE.

Cardiac output and oxygen uptake relationship during physical effort in men and women over 60 years old

This study investigated the relationship between oxygen uptake (VO(2)), cardiac output (Q), stroke volume (SV), and heart rate (HR) in 54 men and 77 women (age = 69 +/- 5 years) during incremental effort. Subjects performed a maximal cycle-ergometer test and VO(2) was directly measured. HR and SV were assessed by ECG and cardiograph impedance. Regression equations were calculated for Q-VO(2), HR-VO(2), and Q-HR relationships. The equations obtained for women were (a) Q (l min(-1)) = 2.61 + 4.67 VO(2) (l min(-1))(r(2) = 0.84); (b) HR (bpm) = 62.03 + 46.55 VO(2) (l min(-1)) (r (2) = 0.72); (c) SV (ml) 100:6[1 - e(-2.6 VO2 (1 min-1))] (r (2) = 0.41); (d) HR (bpm) = 41.48 + 9.24 Q (l min(-1)) (r (2) = 0.73). Equations for men were (a) Q (l min(-1)) = 2.52 + 5.70 VO(2) (l min(-1)) (r (2) = 0.89); (b) HR (bpm) = 66.31 + 32.35 VO(2) (l min(-1)) (r (2) = 0.72); (c) [1 - e(-1.7 VO2 (1 min-1))] (r (2) = 0.47); (d) HR (bpm) = 56.33 + 5.25 Q (l min(-1)) (r (2) = 0.69). The intercepts for Q-VO(2) and HR-VO(2) equations were similar for both genders, but the slopes were different (P < 0.05). The SV increased from baseline to 50-60% of VO(2) peak in both groups. No gender effect was found in SV increasing pattern, but the absolute values were in general higher for men (P > 0.05). A significant difference between men and women was observed for both slopes and intercepts in the Q-HR relationship (P < 0.05). In conclusion, (a) Q-VO(2) relation was linear during progressive effort; (b) regression intercepts were similar, but the slopes were higher for men compared to women; (c) SV-VO(2) relationship was nonlinear and maximum SV was reached at very submaximal workload; (d) older men exhibited higher Q upward potential as well higher SV but lower HR for a given submaximal workload than women of similar age.

Ease of noninvasive measurement of cardiac output coupled with peak VO2 determination at rest and during exercise in patients with heart failure

Peak oxygen consumption (VO2) is a powerful prognostic predictor of survival in patients with heart failure (HF) because it provides an indirect assessment of a patient's ability to increase cardiac output (CO). However, many peripheral factors affect VO2. Inert gas rebreathing using low-concentration soluble and insoluble inert gases can derive CO by the Fick principle. The Innocor rebreathing system uses an oxygen-enriched mixture of an inert soluble gas (0.5% nitrous oxide) and an inert insoluble gas (0.1% sulfur hexafluoride) measured by photoacoustic analyzers over a 5-breath interval. The practicality of this device in measuring CO and VO2 during exercise was assessed in patients with HF. Ninety-two consecutive exercise tests were prospectively performed in 88 patients with HF using the Innocor system. Incremental bicycle exercise was performed with CO measurements at rest, at 50 W, and at peak exercise. The mean age of the 68 men and 20 women was 54 +/- 13 years; 33% had coronary artery disease, and 67% had dilated cardiomyopathy. The mean left ventricular ejection fraction was 24 +/- 9%. Patients were able to rapidly learn the rebreathing technique and easily integrate it into the exercise protocol. Eighty-six percent of the tests had successful measurement of metabolic and cardiac output data. Mean CO at rest was 3.5 +/- 1.1 L/min and increased to 7.2 +/- 2.7 L/min. Mean peak VO2 was 12.6 +/- 4.7 ml/kg/min. A significant linear correlation was observed between peak VO2 and peak CO (r = 0.64, p <0.0001). In conclusion, combined metabolic stress testing with inert gas rebreathing can be easily performed in patients with HF.

Oral L-arginine improves hemodynamic responses to stress and reduces plasma homocysteine in hypercholesterolemic men

When administered intravenously, L-arginine substantially reduces blood pressure (BP) and peripheral vascular resistance in healthy adults and in patients with vascular disease. Oral L-arginine has been shown to improve endothelial function; however, it is not clear whether oral administration has significant effects on systemic hemodynamics. In a randomized, placebo-controlled, crossover study we tested whether oral L-arginine (12 g/d for 3 wk) affected hemodynamics, glucose, insulin, or C-reactive protein in 16 middle-age men with hypercholesterolemia. After each treatment, hemodynamic variables were measured at rest and during 2 standardized stressor tasks (a simulated public-speaking task and the cold pressor). Regardless of treatment, the stressor tasks increased BP and heart rate (P < or = 0.02). Relative to placebo, L-arginine changed cardiac output (-0.4 L/m), diastolic BP (-1.9 mm Hg), pre-ejection period (+3.4 ms), and plasma homocysteine (-2.0 micromol/L) (P < or = 0.03). The change in plasma L-arginine was inversely correlated with the change in plasma homocysteine (r = -0.57, P = 0.03). Contrary to the results of previous studies of L-arginine administered intravenously, oral administration did not affect total peripheral resistance or plasma insulin. Oral L-arginine also did not affect plasma glucose, C-reactive protein, or lipids. This pattern of findings is consistent with the hypothesis that oral L-arginine reduces BP. This study is the first to describe a hemodynamic mechanism for the hypotensive effect of oral L-arginine and the first to show substantial reductions in homocysteine with oral administration.

Validity of the Adaptive Filter for Accurate Measurement of Cardiac Output in Impedance Cardiography

The purpose of this study was to assess the validity of an adaptive filter, the scaled Fourier linear combiner (SFLC), in the impedance cardiography (ICG). Eight healthy males underwent constant-load bicycle exercise at different intensities from unloaded to near maximal intensity. The stroke volume (SV) and cardiac output (Q) measured by ICG at each condition were compared with those by the CO2 rebreathing method. We found that the noises were greatly reduced in the impedance waveform and that the inflection points, so-called the B- and X-points, were clearly detected even during strenuous exercise using the SFLC. Although a high correlation was observed between Qs measured by the two methods, the mean values of Qs in each method differed significantly and the regression line also differed significantly from the identity line. Likewise, a significant correlation was observed between SVs obtained by the two methods, but a significant difference in the group mean values and a trend of the regression line were observed. These findings suggest that the use of SFLC in ICG improves the performance in eliminating the noises and in detecting the inflection points in the waveform, thereby contributing to the accurate and beat-to-beat measurements of SV and Q especially during exercise.

Cardiovascular responses during submaximal electrical stimulation-induced leg cycling in individuals with paraplegia

This study investigated the cardiovascular responses during electrical stimulation-induced leg cycling (ES-LCE) in people with paraplegia (PARA) compared with voluntary leg cycling (VOL) at similar levels of oxygen uptake in able-bodied (AB) individuals. Six PARA with sensory and motor complete spinal cord lesions (TS-T9) and six AB participated in this study. Oxygen uptake (VO2), stroke volume (SV), heart rate (HR) and cardiac output (Q) were measured at rest and during submaximal, steady-state leg cycling. At the highest power output achieved (9.2 +/- 2.4 W for PARA versus 42.8 +/- 1.0 W for AB), VO2 was augmented above resting levels to 0.75 +/- 0.11 min(-1) in PARA and to 0.74 +/- 0.071 min(-1) in AB. HR and SV were also increased during ES-LCE in PARA (92.1 +/- 8-6 beats min(-1) and 93.9 +/- 11.3 ml bea(-1), respectively) and during VOL in AB (83.9 +/- 9.2 beats min(-1) and 89.7 +/- 9.0 ml beat(-1), respectively). At an equivalent submaximal VO2, HR and SV were not different between the two groups, however, Q was higher in PARA (6.6 +/- 0.7 versus 4.1 +/- 0.9 1 min l(-1) deltaVO2). These data suggest that ES-LCE at relatively low power outputs elicits increases in several cardiovascular variables in PARA. Furthermore, it is possible that ES-LCE leads to a 'hyperkinetic circulation' (a greater Q for a given VO2).

The influence of left lateral position on cardiac output changes after head up tilt measured by impedance cardiography

BACKGROUND

The value of the impedance cardiography (IC) method for measuring cardiac output (CO) with the subject in the left lateral position has not yet been established. We compared the CO after a 30 degrees head-up tilt with the subjects in the supine and left lateral position.

METHODS

Thirty healthy young volunteers were placed in the supine horizontal position. CO, stroke volume (SV) and heart rate (HR) were measured for five minutes using impedance cardiography (NCOMM3, BoMed Medical Manufacturing, Location). Then a 30 degrees head-up tilt was done and the measurements were continued for an additional five minutes. After that the subjects were placed in the left lateral horizontal position and the measuring procedure was repeated.

RESULTS

After the tilt, SV and cardiac index (CI) decreased and HR increased statistically significantly in the supine and in the left lateral position. SV and CI also decreased statistically significantly but HR did not change after the shift from the supine to the left lateral position. Although CI was smaller in the left lateral position, the time course of CI change after the tilt was identical in the supine and in the left lateral position.

CONCLUSION

When using the IC method of SV measurement, the absolute value of the CI changes when moving from the supine to lateral positions. It is not clear whether this change is physiologic or an artifact of the measurement technique. However, changes in CI in response to a 30 degree head up tilt are the same in either position. We conclude that changes in CI can be measured with the IC method in the lateral position.